NextPoint Therapeutics is based in Cambridge, Massachusetts. It has raised $123M in total funding. Latest round: Series B.
NextPoint Therapeutics is based in Cambridge, Massachusetts. NextPoint Therapeutics has raised $123M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in February 2024. The round record for NextPoint Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Catalio Capital Management, Leaps by Bayer, Sanofi Ventures, Invus, MPM Capital Management, Binney Street Capital and 3 others. 9 distinct backers are named across the disclosed rounds.
We update the NextPoint Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Cambridge and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026